Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07GWZ
|
|||
| Former ID |
DIB014996
|
|||
| Drug Name |
NT-501 CNTF
|
|||
| Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 1/2 | [1] | |
| Company |
Neurotech usa
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ciliary neurotrophic factor (CNTF) | Target Info | Modulator | [2] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| Jak-STAT signaling pathway | ||||
| WikiPathways | Differentiation Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01648452) CNTF Implants for CNGB3 Achromatopsia. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Neurotech. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.